AlphaFold predicted structure
CYP51A1 · Q16850

Mean pLDDT
90.4/ 100
Very high
509 residues
Confidence breakdown
- Very high(≥ 90)76%
- Confident(70–90)15%
- Low(50–70)6%
- Very low(< 50)4%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cytochrome P450 family 51 subfamily A member 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Bilateral congenital or childhood onset cataracts
BIALLELIC, autosomal or pseudoautosomalStructural eye disease
Developmental cataract
early-onset non-syndromic cataract
cataract
Prolonged QT interval
neurodegenerative disease
long QT syndrome 11
Abnormality of the cardiovascular system
long QT syndrome 1
cardiac arrest
Wolff-Parkinson-White syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Lanosterol 14-alpha demethylase
Sterol 14alpha-demethylase that plays a critical role in the cholesterol biosynthesis pathway, being cholesterol the major sterol component in mammalian membranes as well as a precursor for bile acid and steroid hormone synthesis (PubMed:20149798, PubMed:8619637, PubMed:9559662). Cytochrome P450 monooxygenase that catalyzes the three-step oxidative removal of the 14alpha-methyl group (C-32) of sterols such as lanosterol (lanosta-8,24-dien-3beta-ol) and 24,25-dihydrolanosterol (DHL) in the form of formate, and converts the sterols to 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol and 4,4-dimethyl-8,14-cholestadien-3beta-ol, respectively, which are intermediates of cholesterol biosynthesis (PubMed:20149798, PubMed:8619637, PubMed:9559662). Can also demethylate substrates not intrinsic to mammals, such as eburicol (24-methylene-24,25-dihydrolanosterol), but at a lower rate than DHL (PubMed:9559662)
CYP51A1 · Q16850

Mean pLDDT
90.4/ 100
Very high
509 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0